SERPINC1 and bacterial infectious disease with sepsis: Treatment with infusions of the anticoagulants Antithrombin III (AT III) and activated protein C can attenuate mortality in animal models of bacterial sepsis [17,18] and activated protein C can improve outcome in placebo-controlled trials in humans, even in individuals with no overt clinical signs of coagulopathy [19].